跳至主要内容
临床试验/CTRI/2025/09/095262
CTRI/2025/09/095262招募中3 期

Comparison of toxicities and locoregional control between two high dose rate intracavitary brachytherapy regimens in the patients receiving curative treatment for carcinoma cervix: A Randomised controlled trial

Dept of Radiotherapy1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2025年9月30日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
102
试验地点
1
主要终点
to compare acute as well as late bowel and bladder toxicities between the 2 regimens.

研究概览

简要总结

The objective of the study is to see if it is feasible to reduce the duration of curative treatment for carcinoma cervix without increasing the acute and late toxicity by adapting the newer regimen.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
Female

入选标准

  • KPS a more than 70 Stage IB2 to IVA Baseline blood investigation are within normal limit.
  • No previous treatment for the same.

排除标准

  • 未提供

结局指标

主要结局

to compare acute as well as late bowel and bladder toxicities between the 2 regimens.

时间窗: At first follow up which is at 8 weeks

次要结局

  • To compare loco regional control between the two regimens(At first follow up at 8 weeks, at second follow up at 16 weeks & at third follow up at 24 weeks)

研究者

发起方
Dept of Radiotherapy
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Ankita Prusty

IGMC SHIMLA

研究点 (1)

Loading locations...

相似试验